Gene transfer of tissue inhibitor of metalloproteinase-2 inhibits metalloproteinase activity and neointima formation in human saphenous veins

Gene Therapy

Volumn 5, Issue 11, 1998, Pages 1552-1560

  George, S J ^a   Baker, A H ^a   Angelini, G D ^a   Newby, A C ^a  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

Author keywords

Adenovirus; Gene therapy; Smooth muscle cell; Tissue inhibitor of metalloproteinase; Vein graft

Indexed keywords

METALLOPROTEINASE; TISSUE INHIBITOR OF METALLOPROTEINASE;

ADENOVIRUS; ARTICLE; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; ENZYME INHIBITION; GENE THERAPY; GENE TRANSFER; HUMAN; HUMAN TISSUE; INTIMA; NONHUMAN; ORGAN CULTURE; PRIORITY JOURNAL; SAPHENOUS VEIN; SMOOTH MUSCLE;

ADENOVIRIDAE; DNA VIRUSES;

EID: 0031771145     PISSN: 09697128     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.gt.3300764     Document Type: Article

References (50)

1. Marwick C. Coronary bypass grafting: economics, indudlng rehabilitation. Curr Opin Cardiol 1994; 9: 635-640.
2. Izzat M, West R, Bryan A. Coronary artery bypass surgery: current practice in the United Kingdom. Br Heart J 1994; 71: 382-385.
3. Cox J, Chiasson D, Gotlieb A. Stranger in a strange land: the pathogenesis of saphenous vein graft stenosis with emphasis on structural and functional differences between veins and arteries. Prog Cardiovasc Dis 1991; 34: 45-68.
4. Bryan A, Angelini G. The biology of saphenous vein graft occlusion: etiology and strategies for prevention. Curr Opin Cardiol 1994; 9: 641-649.
5. Davies M, Hagen P-O. Pathobiology of intimai hyperplasia: a review. Eur J Vasc Surg 1995; 9: 7-18.
6. Birkedal-Hansen H et al. Matrix metallproteinases: a review. Crif Rev Oral Biol Med 1993, 4: 197-250.
7. George SJ, Zaltsman AB, Newby AC. Surgical preparative injury and neointima formation increase MMP-9 expression and MMP2 activation in human saphenous vein. Cardiovascular Res 1997; 33: 447-459.
8. George S, Newby A. A metalloproteinase inhibitor (Ro 31-9790) inhibits smooth muscle cell proliferation and migration and neointima formation in human saphenous vein. Eur Heart J 1996; 17: (Abstr. 1062).
9. Bendeck MP, Irvin C, Reidy MC. Inhibition of matrix metalloproteinase activity inhibits smooth muscle cell migration but not neointimal thickening after arterial injury. Circ Res 1996; 78: 38-43.
10. Zempo N et al. Regulation of vascular smooth muscle cell migration and proliferation in vitro and in injured rat arteries by a synthetic matrix metalloproteinase inhibitor. Arterioscler Thromb Vase Biol 1996; 16: 28-33.
11. Forough R et al. Overexpression of tissue inhibitor of matrix metalloproteinase-1 inhibits vascular smooth muscle cell functions in vitro and in vivo. Circ Res 1996; 79: 812-820.
12. George S et al. Adenovirus-mediated gene transfer of the human TIMP-1 gene inhabits SMC migration and neointima formation in human saphenous vein. Hum Gene Ther 1998; 9: 867-877.
13. Docherty AJP et al. Sequence of human tissue inhibitor of metalloproteinases and its identity to erythroid-potentiating activity. Nature 1985; 318: 66-69.
14. Stetler-Stevenson WG et al. Tissue inhibitor of metalloproteinases-2 (TLMP-2) mRNA expression in tumor cell lines and human tumor tissues. J Biol Chem 1990; 265: 13933-13938.
15. Uria JA et al. Structure and expression in breast tumors of human TTMP-3, a new member of the metalloproteinase inhibitor family. Cancer Res 1994; 54: 2091-2094.
16. Leco KJ et al. Murine tissue inhibitor of metaIloproteinases-4 (Timp-4): CDNA isolation and expression in adult mouse tissues. Febs Lett 1997; 401: 213-217.
17. Bode W et al. The X-ray crystal structure of the catalytic domain of human neutrophil collagenase inhibited by a substrate analogue reveals the essentials for catalysis and specificity. EMBO J 1994; 13: 1263-1269.
18. Leco KJ et al. Tissue inhibitor of metalloproteinases-3 (TIMP-3) is an extracellular matrix-associated protein with a distinctive pattern of expression in mouse cells and tissues. J Biol Chem 1994; 269: 9352-9360.
19. Baker AH, Zaltsman AB, George SJ, Newby AC. Divergent effects of tissue inhibitor of metalloproteinase-1, -2 or -3 overexpression on rat vascular smooth muscle cell invasion, proliferation and death in vitro: TTMP-3 promotes apoptosis. J Clin Invest 1998; 101: 1478-1487.
20. Fabunmi RP et al. Divergent regulation by growth-factors and cytokines of 95-kDa and 72-kDa gelatinases and tissue inhibitors of metalloproteinase-1, -2 and -3 in rabbit aortic smooth muscle cells. Biochem J 1996; 315: 335-342.
21. Tripathy SK, Black HB, Goldwasser E, Leiden JM. Immune responses to transgene-encoded proteins limit the stability of gene expression after injection of replication-defective adenovirus vectors. Nature Med 1996; 2: 545-550.
22. Howard EW, Bullen EC, Banda MJ. Preferential inhibition of 72and 92-kDa gelatinases by tissue inhibitor of metalloproteinases2. J Biol Chem 1991; 266: 13070-13075.
23. Ward RV et al. Tissue inhibitor of metalloproteinases-2 inhibits the activation of 72 kDa progelatinase by fibroblast membranes. Biochem Biophys Acta 1991; 1079: 242-246.
24. Goldberg GI et al. Human 72K type IV collagenase forms a complex with a tissue inhibitor of metalloproteases designated TIMP-2. Proc Natl Acad Sci USA 1989; 86: 8207-8211.
25. Fridrnan R et al. Domain-structure of human 72-kDa gelatinase type-IV collagenase characterization of proteolytic activity and identification of the tissue inhibitor of metalloproteinase-2 (TIMP-2} binding regions. J Biol Chem 1992; 267: 15398-15405.
26. Murphy G et al. The C-terminal domain of 72 kDa gelatinase A is not required for catalysis, but is essential for membrane activation and modulates interactions with tissue inhibitors of metalloproteinases. Biochem J 1992; 283: 637-641.
27. Strongin AY et al. Mechanism of cell surface activation of 72 kDa type IV collagenase. J Biol Chem 1995; 270: 5331-5339.
28. Corcoran ML, Stetler-Stevenson WG. Tissue inhibitor of metalloproteinase-2 stimulates fibroblast proliferation via a cAMPdependent mechanism. J Biol Chem 1995; 270:13453-13459.
29. Hayakawa T, Yamashita K, Ohuchi E, Sninagawa A. Cell growth-promoting activity of tissue inhibitor of metalloproteinases-2 (TIMP-2). J Cell Sci 1994; 107: 2373-2379.
30. Kranzhofer A, Baker AH, George SJ, Newby AC. Expression of tissue inhibitor of metalloproteinases-l, -2 and -3 during neointima formation in organ cultures of human saphenous vein. Arterioscler Thrcmb Vase Biol (in press).
31. Chen SJ, Wilson JM, Muller DWM. Adenovirus-mediated gene transfer of soluble vascular cell adhesion molecule to porcine interposition vein grafts. Circulation 1994; 89: 1922-1928.
32. Kupfer J et al. High-efficiency gene transfer to autologous rabbit jugular vein grafts using adenovirus-transferrin/polylysineDNA complexes. Hum Gene Ther 1994; 5:1437-1443.
33. Channon KM et al. Efficient adenoviral gene transfer to early venous bypass grafts: comparison with native vessels. Cardiovasc Res 1997; 35: 505-513.
34. Soyombo AA et al. Intimal proliferation in an organ culture of human saphenous vein. Am J Pathol 1990; 137: 1401-1414.
35. Clowes AW, Reidy MA, Clowes MM. Mechanisms of stenosis after arterial injury. Lab Invest 1983; 53: 513-510.
36. Ferns G AA et al. Inhibition of smooth muscle accumulation after angioplasty by an antibody to PDGF. Science 1991; 253: 11291132.
37. Bendeck MP et al. Smooth muscle cell migration and matrix metalloproteinase expression after arterial injury in the rat. Circ Res 1994; 75: 539-545.
38. Murphy AN, Unsworth EJ, Stetler-Stevenson WG. Tissue inhibitor of metalloproteinases-2 inhibits bFGF-induced human microvascular endothelial cell proliferation. J Cell Physiol 1993; 157: 351-358.
39. DeClerck YA et al. Inhibition of invasion and metastasis in cells transfected with an inhibitor of metalloproteinases. Cancer Res 1992; 52: 701-708.
40. Imren S et al. Overexpression of tissue inhibitor of metalloproteinases-2 by retrovirus-mediated gene transfer in vivo inhibits tumor growth and invasion. Cancer Res 1992; 56: 2891-2895.
41. Will H et al. The soluble catalytic domain of membrane type 1 matrix metalloproteinase cleaves the propeptide of progelatinase a and initiates autoproteolytic activation. J Biol Chem 1996; 271: 17119-17123.
42. Meikle MC, Bord S, Hembry RM, Reynolds JJ. Rabbit calvarial osteoblasts in culture constitutively synthesize progelatmase-a, and Timp-1 and Timp-2. Biochem Biophys Acta 1994; 1224:99-102.
43. Baker AH et al. Development of recombinant adenoviruses that drive high level expression of the human metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 and -2 genes: characterization of their infection into rabbit smooth muscle cells and human MCF-7 adenocarcinoma cells. Matrix Biol 1996; 15: 383-395.
44. Wilkinson GWG, Akrigg A. Constitutive and enhanced expression from the CMV major IE promoter in a defective adenovirus vector. Nucleic Acids Res 1992; 20: 2233-2239.
45. George SJ, Fabunmi RP, Williams A, Newby AC. An essential role for platelet derived growth factor in neointima formation in human saphenous vein in vitro. Atherosclerosis 1996; 120: 227-240.
46. Pederson DC, Bowyer DE. Endothelial injury and healing in vitro. Am J Pathot 1985; 119: 264-272.
47. Heussen C, Dowdle E. Electrophoretic analysis of plasminogen activators in polyacrylamide gels containing sodium dodecyl sulfate and co-polymerized substrates Anal Biochem 1980; 102: 196-202.
48. Southgate KM, Davies M, Booth RFC, Newby AC. Involvement of extracellular matrix degrading metalloproteinases in rabbit aortic smooth muscle cell proliferation. Biochem J 1992; 288: 93-99.
49. Ward RV, Hembry RM, Reynolds J, Murphy G. The purification of tissue inhibitor of metalloproteinases-2 from its 72 KDa progelatinase complex: demonstration of the biochemical similarities of tissue inhibitor of metalloproteinases-2 and tissue inhibitor of metalloproteinases-1. Biochem J 1991; 278: 179-187.
50. Galis ZS, Sukhova GK, Libby P. Microscopic localization of active proteases by in situ zymography: detection of matrix metalloprotinase activity in vascular tissue. FASEB J 1995; 9: 974-980.